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Mitral regurgitation (MR) poses a significant clinical burden in the adult population, which is expected to in-
crease even more with the ever prolonging life expectancies in developed countries. New technology has brought
MR, once exclusively the arena of cardiac surgeons, to the attention of interventional cardiologists. A variety of
device-oriented transcatheter strategies have evolved in recent years. A comprehensive understanding of mitral
valvular anatomy is crucial for the selection of patients, the implementation of devices, and further refinements
of these transcatheter techniques if they are eventually to produce procedural and clinical success. The aim of
this review is to elucidate the morphology of the mitral valvular complex, integrating key anatomical features
into the developing transcatheter options for the treatment of MR. (J Am Coll Cardiol 2010;56:617–26)
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ublished by Elsevier Inc. doi:10.1016/j.jacc.2010.04.030s
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lalvular heart disease frequently affects the adult population
n developed countries (1). Because age is the dominant risk
actor and is uncontrollable, the incidence of such problems
ill rise. In the U.S., 0.7% of young adults below the age of
5 years have moderate to severe valvular heart disease, a
roportion increasing to one-sixth of those over 75 years of
ge. In every age group, mitral regurgitation (MR) is the
ost common valvular disorder, with a global prevalence of
.7%, increasing to 10% in those age 75 years.
The mitral valvular apparatus is a complex anatomical and
unctional entity (2). One or more flaws in its components
an result in MR. According to etiology and pathophysiol-
gy, MR can be divided somewhat artificially into primary
r organic and secondary or functional categories (3,4). In
rimary lesions, 1 or more of the components of the mitral
alve (MV) itself is deranged, whereas in secondary lesions,
eometric and/or functional changes of the left ventricle
LV) are the core of the problem.
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010, accepted April 26, 2010.Despite guidelines for the management of patients with
evere MR, a recent European survey established that
ne-half of these patients are not referred for surgery, largely
ecause of their advanced age, the presence of comorbidi-
ies, or impaired LV function (5–7). Even more notably,
epair as opposed to valvular replacement was performed in
nly one-half of those who underwent surgery, mostly
ecause of a lack of institutional expertise in this particular
echnique. The surgical treatment of functional MR re-
ains a subject of debate (8).
This underserved population of patients with severe MR
pens the door for several innovative transcatheter concepts,
hich are comparable with various aspects of surgical repair
9). To take full advantage of these new technologies, it is
xiomatic that those attempting treatment should have
omprehensive knowledge of the anatomy of the mitral
alvular apparatus and its relationship to the LV. Our aim in
his review, therefore, is to address the anatomy of the
itral valvular complex with catheter-based techniques for
alvular repair in mind.
istory
t was the Belgian anatomist and physician Andreas Vesa-
ius, while working in Padua, Italy, who likened the bifoliate
eft atrioventricular valve to a bishop’s mitre, hence the term
mitral valve” (10). The physiology of the working compo-
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Mitral Valve Anatomy and Transcatheter Strategies August 17, 2010:617–26nents of the valve, its 2 leaflets,
can be understood only when
note is taken of their crucial re-
lationships to the adjacent ana-
tomical structures, namely, the
left atrium (LA), the LV, the
aortic valve, the papillary mus-
cles, the tendinous cords, and the
cardiac central fibrous body. In
972, Perloff and Roberts (2) put forward the concept of a
itral valvular complex to underscore this essential and
armonious structural relationship. From a clinical perspec-
ive, the French surgeon Alain Carpentier introduced the
aradigm of the pathophysiologic triad to better define
egurgitation across the valve, pointing out that the under-
ying disease, the first leg of the triad, creates structural or
eometric changes in the valvular apparatus, this being the
econd leg, which may lead to valvular dysfunction as the
hird leg (3,4).
More recently, the extraordinary revolution in cardiac
maging has contributed to better understanding and inte-
ration of the anatomy, physiology, and pathophysiology of
he MV, with 3-dimensional echocardiography, multislice
omputed tomography, and cardiac magnetic resonance
maging all proving invaluable in evaluating valvular regur-
itation and playing a defining role in the development and
xecution of transcatheter valvular therapies (11–16).
Abbreviations
and Acronyms
LA  left atrium/atrial
LV  left ventricle/
ventricular
MR  mitral regurgitation
MV  mitral valve
Figure 1 Anatomical Orientation of the Left Atrioventricular Jun
The ventricular mass has been sectioned along its short axis and photographed fr
Note that the septum is anteriorly located, and the papillary muscles (PM) support
are positioned inferoseptally and superolaterally. Note also that 1 of the leaflets o
aortic-mitral curtain formed by the area of their continuity creating the roof of the lhe Mitral Valvular Complex
or normal closure of the MV, both leaflets must align in the
ame plane as they coapt along their solitary zone of apposition.
o achieve such apposition, it is necessary to have an optimal
ize of the so-called valvular annulus, a geometrically correct
rientation of the papillary muscles giving rise to the tendinous
ords, and appropriate closing forces generated by muscular
ontraction of the LV. Thus, it is necessary to take account not
nly of the mitral valvular apparatus when considering the
alient anatomy but also of the relationship between its
omponents and surrounding structures, such as the atrioven-
ricular conduction axis, the aortic valve, the coronary sinus,
nd the circumflex coronary artery.
he left atrioventricular junction. From an anatomical
erspective, the term “mitral annulus” is a misnomer. The
ssential structure supporting the valvular leaflets is the left
trioventricular junction, this being the D-shaped orifice
ormed at the confluence between the LA walls and the
upporting LV structures (2,10,17,18). On the ventricular
spect, these supporting structures are not exclusively myo-
ardial, because there is an extensive area of fibrous conti-
uity (the so-called aortic-mitral curtain) between the an-
erior leaflet of the MV and the aortic valve in the roof of
he LV (Fig. 1). When considered 3-dimensionally, the
verall atrioventricular junction is nonplanar, with elevated
eptal and lateral segments at the ends of the solitary zone
cardiac apex; the heart is presented in the location it occupies in the thorax.
leaflets of the mitral valve, when assessed in attitudinally appropriate location,
itral valve is in fibrous continuity with the leaflets of the aortic valve, the fibrous
tricle.ction
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August 17, 2010:617–26 Mitral Valve Anatomy and Transcatheter Strategiesf apposition between the leaflets and complementary de-
ressed medial segments along the central component of the
one of apposition, giving a characteristic saddle-shaped
verall appearance (Fig. 2) (19). It is along the depressed
nterior segment of the junction that 1 of the leaflets of the
alve is in fibrous continuity with the noncoronary and left
oronary leaflets of the aortic valve, this extensive area being
ell described as the aortic-mitral curtain (Fig. 1). At either
nd, the central part of the fibrous curtain, which represents
he annulus of the aortic or anterior leaflet of the valve, is
ttached by fibrous expansions, the left and right fibrous
rigones, to the ventricular myocardium (Figs. 3 and 4). The
ight trigone is itself continuous with the membranous
eptum, the combined entity forming the central fibrous
ody, and with the penetrating part of the atrioventricular
onduction axis passing through the atrioventricular com-
onent of the membranous septum (18). Fibroelastic cords
f various firmness and structure extend from the fibrous
rigones through the mural part of the left atrioventricular
unction. It is rare for the cords to form a complete ring to
upport the mural, or posterior, leaflet of the valve. The
o-called annulus, therefore, is much more resistant to
athologic dilation along the aortic as opposed to the mural
eaflet. Especially in its posterior aspects, several deficiencies
n the annular structure are filled with adipose tissue. The
bsence of a well-formed fibrous cord in this particular
osition opposite the aortic-mitral curtain explains its pre-
ilection for annular dilation and calcification, which result
n a disproportional increase in the aortic-to-mural, or
eptal-to-lateral, diameter of the valvular orifice, potentially
recluding adequate leaflet coaptation.
The goal of surgical annuloplasty when the atrioventricular
unction is dilated is to decrease the circumference of the
alvular orifice, the aim being to reduce the septal-to-lateral
iameter by at least 8 mm (20). Transcatheter strategies now
xist to achieve this same goal (Figs. 5A and 5B). Key
Figure 2 3-Dimensional Echocardiographic Reconstruction of th
(Left) Three-dimensional echocardiographic reconstruction of the left atrioventricul
aortic valve (*). The green arrow indicates the right ventricle. (Right) Saddle-shap
septal (S) and lateral (L) segments and complementary depressed segments alongnatomical features for success are the patency of the coronary ainus and the anatomical relationship between the myocardial
omponents of the mural junction, the sinus itself, and the
ircumflex coronary artery. The potential to produce damage to
he atrioventricular conduction axis should also be remembered
Fig. 4).
Transcatheter annuloplasty can be performed indirectly
y reshaping and restraining the valvular orifice via the
oronary sinus (see the following discussion) or by ap-
roaching the junction directly via the LA or LV (9). The
itralign system (Mitralign, Inc., Tewksbury, Massachu-
etts) and Accucinch (Guided Delivery Systems, Inc., Santa
lara, California) are both direct annuloplasty devices.
edicated catheters are advanced retrogradely into the LV
o position anchors to the ventricular side of the posterior
egment of the left atrioventricular junction. By pulling the
nchors together with sutures, the circumference of the
trioventricular junction is reduced. Mitral cerclage annu-
oplasty is a circumferential suture-based concept that com-
ines the indirect and direct techniques (21). A guidewire is
dvanced through the coronary sinus into the first septal
erforating branch of the great cardiac vein and subsequently
irected across a short segment of myocardium to establish a
ight ventricular or right atrial re-entry. The guidewire is then
nsnared and exchanged for a suture and tension fixation
evice. A rigid arch protects the suture at the site where the
oronary sinus crosses the circumflex artery. Annuloplasty can
lso be achieved by applying thermal radiofrequency to the
broadipose tissue of the left atrioventricular junction, produc-
ng shrinkage without jeopardizing the cardiac vessels or mitral
alvular leaflets (QuantumCor system, QuantumCor, Inc.,
othell, Washington) (22).
he valvular leaflets. The MV is bifoliate. The leaflet
lassically described as being anterior is in fibrous continuity
ith 2 of the leaflets of the aortic valve, hence the alternative
erm “aortic leaflet.” The opposing posterior leaflet is also
ppropriately described as the mural leaflet (10,18). The
ft Atrioventricular Junction
tion, demonstrating the location of the mitral valve (red arrow) relative to the
pearance of the mitral atrioventricular junction or “annulus.” Note the elevated
entral zone of apposition.e Le
ar junc
ed ap
the cortic leaflet has a wider surface with a shorter base and
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Mitral Valve Anatomy and Transcatheter Strategies August 17, 2010:617–26uards one-third of the left atrioventricular junction. It
eparates the LV inflow and outflow tracts. The mural
eaflet is shallower but wider, guarding two-thirds of the
unctional circumference. The surface area of both leaflets
aken together is 2.5 times the area of the valvular orifice. In
ystole, the leaflets coapt over a height of, on average, 8 mm,
iving an “overlapping reserve” or “coaptation reserve” in
ase of annular dilation (Fig. 6). The zone of apposition
etween the leaflets is obliquely oriented relative to the
rthogonal planes of the body but is recognized as the
mitral smile” on short-axis echocardiography. Its 2 ends are
ositioned inferoseptally and superolaterally (Fig. 1), al-
hough these positions are currently incorrectly described as
eing posteromedial and anterolateral (17). Slits in the
ural leaflet create 3 scallops, while further segments of
eaflet tissue are found at the ends of the solitary zone of
pposition, this zone representing the true valvular commis-
ure. These various components of the mural leaflet produce
more flexible structure compared with the more rigid
ortic leaflet and combine with the dynamic motions of the
unction to produce the so-called sphincter mechanism.
When regurgitation across the valve is the consequence of
nappropriate coaptation of the leaflets, one approach to
Figure 3 The Aortic-Mitral Curtain and Fibrous Continuity
The heart has been opened through the outflow tract of the left ventricle, showing
the area of fibrous continuity between the aortic leaflet of the mitral valve and the
tain in the roof of the left ventricle. The ends of the area of fibrous continuity are
tinuous with the membranous septum, the conjoined are being known as the centurgical treatment is to create a double orifice by suturing aogether the free edges of the middle segments of the
nterior and posterior leaflets, the edge-to-edge or Alfieri
titch (23). This technique has now been adapted for
ranscatheter use, and has received Conformité Européenne
ark approval as the MitraClip (Evalve, Inc., Menlo Park,
alifornia). Unlike the surgical approach, however, the
ranscatheter technique does not currently involve an annu-
oplasty, although the clinical value of a combined approach
emains debatable (24).
The Alfieri stitch is used for organic as well as functional
R (25). A transseptal puncture is required to advance the
atheter to the LA. The MitraClip uses 1 or 2 clips to join
he 2 leaflets at the level of the middle scallop of the mural
eaflet. After implantation, a tissue bridge forms across the
lip between the leaflets, providing additional support for
he repair and preventing septal-to-lateral dilation. Impor-
antly, the contractile function of the atrioventricular junc-
ion is preserved. For MitraClip trial inclusion, several
natomical premises must be fulfilled. First, the regurgitant
et must be centered at the level of the zone of coaptation in
he central two-thirds of the line of coaptation. Second,
oaptation length of at least 2 mm, and a depth below the
itral annular plane of no more than 11 mm, must be
ntricular surface of the aortic leaflet of the mitral valve. Note how the ends of
ronary and left coronary leaflets of the aortic valve anchor the aortic-mitral cur-
t and right fibrous trigones. As can be seen, the right fibrous trigone is itself con-
ous body.the ve
nonco
the lef
ral fibrvailable for coaptation between the leaflets, although the
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August 17, 2010:617–26 Mitral Valve Anatomy and Transcatheter Strategiesoaptation depth may be less important. Should one of the
eaflets be flail, the gap and the width of the flail segment
an be no more than 10 and 15 mm, respectively (Fig. 7).
endinous cords and papillary muscles. The mitral val-
ular leaflets, via the tendinous cords and papillary muscles,
re connected to the LV free wall like the shrouds of a
arachute (2,10,18). The fibrocollagenous tendinous cord,
r chordae tendineae, take origin from the papillary muscles,
ifurcate several times, and attach to the free edges and
entricular aspects of both leaflets. The cords are thinnest at
heir sites of insertion on the leaflets, and this is the site of
redilection for chordal rupture. Most of the cords insert
niformly along the free margins of the leaflets, thus
reventing marginal prolapse and aligning the zone of
oaptation. Strut cords attach to the ventricular aspect of the
ortic mitral leaflet (Fig. 1), precluding billowing and
erving to distribute load throughout the leaflet. The basal
ords originate directly from the ventricular wall and attach
xclusively to the ventricular surface of the mural leaflet,
ontributing to ventricular geometry and fortifying the
entricular aspect of the atrioventricular junction.
The cords arise from the paired papillary muscles, which
rise from the apical to middle thirds of the LV free wall,
ith each muscle made up of a variable number of heads. It
s conventional wisdom to state that the superolateral
uscle is supplied by 1 or more branches of the circumflex
rtery, or by diagonal branches, whereas the inferoseptal
apillary muscle is supplied by a single branch of the circumflex
r right coronary artery, depending on coronary artery domi-
ance. Because of its single vascular supply, the inferoseptal
uscle in particular is susceptible to coronary ischemia. Or-
Figure 4 Anatomical Structures Surrounding the Left Atrioventr
Relationships of the mitral valve as seen by the surgeon operating through the rooanic disease usually involves these components of the mitral ralvular complex (26). Myxomatous degeneration can render
he cords inappropriately long and abolish their specific elastic
roperties, thus inducing prolapse. Fibroelastic deficiency pro-
uces the exact opposite phenomenon. There will be retraction
f tissue, making the cords vulnerable to rupture and resulting
n a partial or total flail leaflet. As already discussed, it is the
itraClip that represents the transcatheter approach targeting
egenerative regurgitation.
ntegration of the LA and LV. The myocardium of the
A and LV is intimately connected to support the mural
eaflet of the MV. The term “disjunction” refers to the fact
hat the valvular tissue hinges directly from the myocardium
ather than being supported by an anatomical cordlike
tructure (27). The insertion of the LA myocardium follows
he general contour of the junction, as opposed to the LV
yocardium, which has no relationship with the aortic
eaflet of the MV. Indeed, the LV outflow tract interposes
etween the aortic leaflet of the MV and the ventricular
eptum (10). The posteroinferior wall of the LV, in con-
rast, supports directly the mural leaflet through the basal
ords. Given the tight interdependence with the ventricular
ree wall and the unique arrangements of the different
omponents, changes in ventricular geometry can have
erious consequences for mitral valvular dynamics (28). LV
ural dyskinesia can change the orientation of the basal
ords, producing a tethering effect on the mural leaflet.
ore global LV dilation can displace the papillary muscles
n an apical direction, creating tenting of the leaflets with
ack of coaptation and eventual regurgitation.
Catheter techniques have been developed to remodel the
V by introducing a transventricular bridge between ante-
r Junction
e left atrium.icula
f of thior and posterior pads, placed through the pericardial space
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Mitral Valve Anatomy and Transcatheter Strategies August 17, 2010:617–26iCoapsys, Edwards Lifesciences, Irvine, California). By
rawing the pads together, it is possible to change the LV
eometry, potentially narrowing the atrioventricular junc-
ion and optimizing the orientation of the papillary muscles
elative to the leaflets, although this technology is currently
n abeyance (29).
Transcatheter replacement of the MV, via either a
ransapical or a transseptal approach, is a much anticipated
Figure 5 Devices for Indirect Transcatheter Mitral Annuloplasty
(A) Devices available for indirect transcatheter mitral annuloplasty. (Left) From to
MONARC (Edwards Lifesciences, Irvine, California), and Percutaneous Transvenous
The MitraClip (Evalve, Inc., Menlo Park, California). (B) Devices to reduce mitral re
lar vein; OTW  over-the-wire; R/O  radio-opaque.echnique. Several anatomical hurdles remain. The inherent (adial force needed to anchor the stented valve might
queeze the LV outflow tract, while the tendinous cords
ight impede positioning, expansion, and anchoring of the
rosthesis (30,31). The asymmetry of the mitral orifice is
lso a technical challenge.
oronary venous and arterial anatomy. In a venous sys-
em known to show marked variability, consistent entities
re the great cardiac vein and the coronary sinus (Fig. 8)
MitraClip and Devices to Reduce Mitral Regurgitation
ttom, the Carillon (Cardiac Dimensions, Inc., Kirkland, Washington), Edwards
l Annuloplasty (PTMA) (Viacor, Inc., Wilmington, Massachusetts) devices. (Right)
tion through transcatheter repair of the mitral valve. AIV  anterior interventricu-and
p to bo
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August 17, 2010:617–26 Mitral Valve Anatomy and Transcatheter Strategieshe anterior interventricular vein, originates at the lower or
iddle third of the anterior interventricular groove (32). It
ollows the groove toward the base of the heart and then
urns inferiorly at the atrioventricular junction, fusing with
Figure 6 Mitral Leaflet Coaptation
The heart has been sectioned along the long axis of the left ventricle, having fixed
arrow indicates the coapting surfaces of the leaflets. Note the strut cords support
ing the ventricular aspect of the mural leaflet. Note also the relationships of the c
Figure 7 Key Anatomical Dimensions for the MitraClip
Anatomical measurements less favorable for the
MitraClip device (Evalve, Inc., Menlo Park, California).fihe oblique vein of the LA, a remnant of the embryonic left
uperior caval vein, to become the coronary sinus. The
iddle cardiac vein runs along the inferior interventricular
roove to empty into the coronary sinus close to its orifice in
he right atrium. At its orifice, the coronary sinus is guarded
y a thin semicircular valve, the Thebesian valve. There is
ignificant variability in the morphology and composition of
his valve, such that it can become a notorious obstacle to
annulation of the sinus (33). The location of the coronary
inus changes as it courses through the left atrioventricular
unction. In over nine-tenths of cases, the body of the sinus
s adjacent to the inferior LA wall, well above and cranial to
he deeper atrioventricular junction (Fig. 6) (12,16,34). It is
losest to the lateral segment of the atrioventricular junction
t the midpoint of the mural leaflet and furthest away at the
nds of the solitary zone of apposition. When there is
ignificant regurgitation, particularly in the setting of isch-
mic cardiomyopathy, the sinus is lifted away from the
osterior segment and conversely moves closer to the ends
f the solitary zone of apposition between the leaflets
11,12). This coincides with flattening of the saddle-shaped
annulus” and an increase in the septal-to-lateral annular
iameter (35). As the sinus approaches its right atrial
ermination and receives several tributaries, its caliber
rows. The sinus is always a close neighbor of the circumflex
rtery, which crosses the venous structure in up to four-
eart with the leaflets of the mitral valve in closed position. The double-headed
ventricular aspect of the aortic leaflet of the valve and the basal cord support-
y sinus and the circumflex artery to the mural leaflet of the valve.the h
ing the
oronarfths of patients. The point of crossing, the length of the
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Mitral Valve Anatomy and Transcatheter Strategies August 17, 2010:617–26verlapping segment, the length of the parallel course, as
ell as the distance of the crossing point to the atrioven-
ricular junction are all highly variable. The great cardiac
ein crosses diagonal or intermediate arterial branches in
ne-sixth of individuals (33).
Several different devices are in development to provide
ndirect transcatheter annuloplasty (36–38). Depending on the
natomical proximity of the coronary sinus to the left atrio-
entricular junction to accomplish an indirect annuloplasty,
owever, has obvious limitations. Coronary arteries can be
inched, and the location of the sinus relative to the annulus
ay be unfavorable, precluding procedural success. Various
maging techniques have been used to identify these spatial
nterrelationships. To date, however, none has been shown to
ccurately predict the suitability of the sinus for the purposes of
ranscatheter annuloplasty, nor could they predict whether the
echnique would jeopardize the circumflex artery. Cardiac
ailure, with at least moderate to severe MR, seems the
entative target indication. With this in mind, we briefly review
he main devices under investigation.
ranscatheter indirect mitral annuloplasty devices. The
ercutaneous Transvenous Mitral Annuloplasty device
Viacor, Inc., Wilmington, Massachusetts) consists of up to
straight and rigid nitinol rods seated in a dedicated
ultilumen polytetrafluoroethylene (Teflon, DuPont, Wil-
ington, Delaware) catheter, which is introduced in the
oronary sinus with its distal atraumatic silicone tip in the
reat cardiac vein down the interventricular groove (38).
he assembly will produce an outward force at its proximal
nd distal ends, resulting in anterior displacement of the
iddle scallop of the mural leaflet and a decrease in the
eptal-to-lateral diameter of the valve. After positioning,
he titanium proximal Percutaneous Transvenous Mitral
nnuloplasty hub is closed and sutured to the subclavian fascia,
s would happen with a permanent pacemaker device.
The Carillon device (Cardiac Dimensions, Inc., Kirkland,
ashington) consists of a curved nitinol arc connecting a
Figure 8 CS and Left CX by Multislice Computed Tomography
Electrocardiographically-gated dual-source 128-slice computed tomographic scan s
tions showing the great cardiac vein (GCV) originating from the CS and extending i
atrioventricular groove showing the entire circumferential course and diameter of t
circumflex coronary artery; LAD  left anterior descending coronary artery.roximal and a distal anchor (36). A dedicated delivery batheter is used to position the distal anchor near the point
t which the great vein enters the anterior interventricular
roove. The device is then passively deployed by retracting
he delivery catheter. During the implantation procedure,
he functional efficacy on regurgitation, and potential coro-
ary compromise, can be evaluated with ability to recapture
he device if needed.
The Edwards MONARC system (Edwards Lifesciences)
s a nitinol assembly with a small distal anchor, a larger
roximal anchor, and a springlike bridging segment (37).
he device is introduced through a delivery catheter. Both
nchors are self-expandable. By retracting the delivery
ystem, the device is deployed, and both anchors are drawn
ogether, displacing the inferior part of the annulus more
uperiorly. The bridge contains biodegradable material,
ausing the system to shrink over the following weeks.
ence, the final result becomes evident only after 4 to 6
eeks. The downside of this system is 2-fold: the impact of
he MONARC system on the dimensions of the valvular
rifice and flow through the coronary arteries cannot be
onitored during the implantation, and the device is not
etrievable. The great cardiac vein must be at least 3 mm
ide to receive the distal anchor, and the total length of the
oronary venous system should be from 14 to 18 mm.
The various indirect coronary sinus annuloplasty devices
ave suffered fractures after implantation. The mechanical
tresses in the coronary sinus are difficult to model and have
ot been fully appreciated. Also, not only the circumflex
rtery and its branches but also the diagonal and interme-
iate branches are at risk for impingement over time. All of
hese devices have been redesigned and require further
tudy.
Indirect remodeling and concomitant reduction in the
ircumference of the valvular orifice through transatrial
xture is pursued with the Transcatheter Septal Sinus
hortening or PS3 device (Ample Medical, Inc., Foster
ity, California) (39). This system creates a transatrial
the morphology of the coronary sinus (CS). (A, B) 3-dimensional reconstruc-
left atrioventricular groove. (C) Cross-sectional plane taken parallel to the left
at vein (arrows), demonstrating its relationship to the coronary arteries. CX howing
nto the
he greridge using an atrial septal occluder and a T-bar element
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imension of the atrioventricular junction. Despite promis-
ng pre-clinical data and the first human experience, no
urther investigational efforts are currently scheduled.
onclusions
he MV is a complex anatomical structure. Normal valvular
echanics require a sophisticated interaction of its compo-
ents, along with the adjacent LV and atrial myocardium.
urgery is currently the standard of care for patients with
evere MR (5,6,40,41). In this respect, repair has a clear
dvantage over replacement, preserving as it does LV
ystolic function, obviating the need for oral anticoagula-
ion, and improving survival (8,42). Unfortunately, surgical
epair is not always feasible, and at many cardiothoracic
enters, the required surgical expertise is unavailable, and
atients end up with MV replacement (43). In addition,
atients do not undergo surgical intervention because of age
nd comorbidities, while the indications for surgery in the
etting of moderate to severe functional regurgitation are
ighly debated (7,8,44). This confers a window of oppor-
unity for the creation of new transcatheter technology.
nowledge of the anatomy of the mitral valvular complex is
rucial for the clinical implementation and further refine-
ent of these technologies. If their efficacy and safety can be
emonstrated in relevant trials, the stage might be set for a
aradigm shift whereby these transcatheter interventions
ould be added to the therapeutic armamentarium in the
eart failure arena and as a potential alternative for surgical
alvular repair in selected cases.
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